X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/biond-biologics-announces-presentation-of-bnd-35-a-novel-anti-ilt3-antibody-for-remodeling-the-tumor-microenvironment-at-the-american-association-for-cancer-research-aacr-2024-annual-meeting-302099399.html
https://www.prnewswire.com/news-releases/biond-biologics-announces-first-patients-dosed-with-bnd-22-sar444881-combinations-in-phase-1-clinical-trial-301552737.html
https://www.prnewswire.com/news-releases/biond-biologics-to-present-at-the-raymond-james-lilrbilt-symposium-301528804.html
https://www.prnewswire.com/news-releases/biond-biologics-announces-closing-of-15-million-series-c-financing-301415227.html
https://www.prnewswire.com/news-releases/biond-biologics-announces-first-patient-dosed-in-phase-1-clinical-trial-of-bnd-22-a-novel-immune-checkpoint-inhibitor-targeting-the-ilt2-receptor-301276510.html
https://www.reuters.com/article/us-health-israel-biond-sanofi-fr/sanofi-israels-biond-biologics-to-collaborate-on-new-cancer-drug-idUSKBN29H1Q3
Market Place
Share 
